Related Experiment Videos
Isolated testicular leukemic relapse. Response to radiation therapy
Urology
|September 1, 1987
Summary
This study found that combined testicular irradiation and chemotherapy effectively controlled leukemia relapse in boys. Optimal control of testicular leukemia was achieved with 2,000-2,400 cGy radiation doses.
Area of Science:
- Pediatric Oncology
- Hematology
- Radiation Oncology
Background:
- Testicular relapse in childhood leukemia presents a significant clinical challenge.
- Isolated testicular leukemia requires specific treatment protocols to prevent systemic dissemination.
Purpose of the Study:
- To evaluate the efficacy of combined testicular irradiation and systemic chemotherapy in managing isolated testicular relapse in boys with leukemia.
- To determine optimal radiation dosage for controlling leukemic infiltration in the testes.
Main Methods:
- Retrospective analysis of 17 boys with leukemia experiencing isolated testicular relapse between 1975 and 1984.
- Diagnosis confirmed via bilateral testicular open-wedge biopsies.
- Treatment involved combined local testicular irradiation and systemic chemotherapy.
Main Results:
- Only 1 out of 17 patients (6%) experienced testicular leukemia as the sole site of relapse.
- Radiation doses between 2,000 and 2,400 cGy, delivered in 10-12 fractions, demonstrated effective control of testicular leukemia.
Conclusions:
- Combined modality treatment is highly effective in managing isolated testicular leukemia in pediatric patients.
- A radiation dose range of 2,000-2,400 cGy appears optimal for achieving sustained control of leukemic infiltration in the testes.